Does intravenous induction dosing among patients undergoing gastrointestinal surgical procedures follow current recommendations: a study of contemporary practice - 21/08/16
, Jia Liu, BS b, Joseph Heng, BA b, Feng Dai, PhD c, Robert B. Schonberger, MD b, Matthew M. Burg, PhD dAbstract |
Study objective |
It is recommended to correct intravenous induction doses by up to 50% for patients older than 65 years. The objectives were to determine (a) the degree to which anesthesia providers correct induction doses for age and (b) additionally adjust for American Society of Anesthesiologists physical status (ASA-PS) class (severity of illness) and (c) whether postinduction hypotension is more common among patients aged >65.
Design |
Retrospective chart review.
Setting |
Academic medical center.
Patients |
A total of 1869 adult patients receiving general anesthesia for GI surgical procedures from February 2013 to January 2014.
Measurements |
Patients were divided into 3 age groups (age <65, 65-79, ≥80 years) and then further stratified into ASA-PS class (I/II vs III/IV). Multiple pairwise comparisons were conducted using Welch t tests for continuous variables to determine whether dosing was different for the older groups vs the younger group; separate analyses were performed within and across ASA-PS class. This approach was also used to determine differences in mean arterial pressure change in the older groups vs the younger group, whereas the rates of hypotension among different age groups were compared by Cochran-Armitage trend test.
Main results |
No significant decrease in dosing between age groups was observed for fentanyl and midazolam. For propofol, there was a significantly lower dosing for older patients: 17% for patients aged 65-79 and 29% for those aged >80, which was still in less than the recommendations. An inverse relationship was observed between propofol dosing and ASA-PS class, but no consistent relationship was noted for fentanyl and midazolam. There were a significantly larger drop in mean arterial pressure and a greater likelihood of hypotension following induction in patients aged 65-79 years and >80 years as compared with those aged <65 years.
Conclusions |
This study shows that the administered dose of anesthetic induction agents is significantly higher than that recommended for patients older than 65 years. This failure to age-adjust dose may contribute to hypotensive episodes.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Higher doses of propofol are administered in elderly patients than recommended. |
• | Practitioners do not adjust for fentanyl and midazolam dose in elderly patients. |
• | Propofol dosing decreases with higher ASA-PS class. |
• | No relationship was noted with fentanyl and midazolam dose and ASA class. |
• | There was a larger drop at induction in MAP in patients aged >65yrs. |
Keywords : Elderly, Gastrointestinal surgery, Geriatric anesthesia, Hypotension, Intravenous anesthetics, Octagenarians, Propofol
Plan
| ☆ | Declaration of conflict of interests: SA, JL, JH, FD, RS, and MB declare no conflicts of interests. |
| ☆☆ | Disclosure: This work was supported in part by Clinical and Translational Science Award grant UL1 RR024139 from the National Center for Advancing Translational Sciences at the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the policy or views of the National Institutes of Health or the United States government. |
Vol 33
P. 208-215 - septembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
